Michael Mullette

Chief Operating Officer at Lykos Therapeutics PBC

Health Technology

Profile

Michael Mullette is currently the Chief Operating Officer at Lykos Therapeutics, Inc. He previously worked as the Managing Director-Canada at Moderna, Inc. from 2020 to 2022.

Michael Mullette active positions

Companies	Position	Start
Lykos Therapeutics PBC Lykos Therapeutics PBC BiotechnologyHealth Technology Part of Multidisciplinary Association for Psychedelic Studies, Lykos Therapeutics, Inc. is a public benefit corporation that focuses on developing and commercializing prescription psychedelics to provide better treatments for people with mental health conditions. The private company is based in San Jose, CA. Lykos Therapeutics aims to catalyze healing and well-being through psychedelic drug development, therapist training programs, and sales of prescription psychedelics, prioritizing public benefit above profit. The company was founded in 2014, and the CEO is Amy Emerson.	Chief Operating Officer	28/02/2022

All active positions of Michael Mullette

Former positions of Michael Mullette

Companies	Position	End
MODERNA, INC.	Corporate Officer/Principal	-

See the detail of Michael Mullette's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Michael Mullette's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
MODERNA, INC.	Health Technology

Private companies	1
Lykos Therapeutics PBC Lykos Therapeutics PBC BiotechnologyHealth Technology Part of Multidisciplinary Association for Psychedelic Studies, Lykos Therapeutics, Inc. is a public benefit corporation that focuses on developing and commercializing prescription psychedelics to provide better treatments for people with mental health conditions. The private company is based in San Jose, CA. Lykos Therapeutics aims to catalyze healing and well-being through psychedelic drug development, therapist training programs, and sales of prescription psychedelics, prioritizing public benefit above profit. The company was founded in 2014, and the CEO is Amy Emerson.	Health Technology